MONKASTA 10 mg. 28 tablets

KRKA
MONKASTA 10 mg. 28 tablets
€ 45.00
Add to Cart
WHAT MONKASTA AND WHAT IT IS USED FOR?
The active substance in Monkasta 10 mg tablets is montelukast, which is a leukotriene receptor antagonist. It blocks naturally situated lungs chemicals called leukotrienes, which cause contraction of airway and pulmonary inflammation, leading to asthma symptoms. Leukotrienes contribute to the onset of the symptoms of allergy. Blocking leukotriene reduces the symptoms of seasonal allergy (also known as seasonal rhinitis or hay fever)
Monkasta be used to treat patients who are not adequately controlled by their treatment and require further treatment.
Patients with asthma and seasonal allergies, Monkasta heal also your seasonal allergy symptoms.
Monkasta helps prevent asthma symptoms that are triggered by exercise.

2. BEFORE YOU TAKE MONKASTA
Do not give Monkasta:
If you are allergic (hypersensitive) to montelukast or any of the excipients in Monkasta

Take special care when taking Monkasta:
It is important Monkasta be taken every night, as your doctor prescribes, even if you have no symptoms or do not get asthma attacks.
Oral Monkasta NOT intended to treat sudden attacks of breathlessness. It will not help in this situation and should never be used for such purpose. In case of attack, the instructions given to you by your doctor should be strictly adhered to is very important to have a medicinal product necessary for such attacks, which is easily accessible at any time.
If you must use inhaled beta-agonist (also known as a bronchodilator or inhaler for relief) more often than usual, you should consult with your doctor as soon as possible.
Monkasta can not replace steroid medicines (inhaled or orally) that you may already use.
Patients with asthma induced by aspirin, taking Monkasta should continue to avoid to take aspirin or other nonsteroidal anti-inflammatory drugs.
Rare condition has been seen in a very small group of patients taking asthma medications, including montelukast, although it has been shown that it causes no montelukast. Seek immediate medical attention if you experience any of these symptoms, especially if they already exist or worsen:
- Influenza-like illness,
- Rapid breathing,
- Erect of chills, stiffness of the limbs and / or
- Rash.

Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any medicines, including medicines obtained without a prescription. Most importantly, tell your doctor if you are taking phenobarbital or phenytoin (used to treat epilepsy), or rifampicin (used to treat tuberculosis and some other infections) because they may decrease the effectiveness of Monkasta.
Monkasta can be used concurrently with other medicinal products used in asthma.

Taking Monkasta with food and drink
You can take medicine with food or without food. Pregnancy and lactation
Consult your doctor before taking any medicines.

pregnancy:
Women who are pregnant, may become pregnant or think they might be pregnant should consult their doctor before they start taking Monkasta.
lactation:
It is not known if montelukast is excreted in human milk. It is necessary to consult with your doctor before you start taking Monkasta if you are breastfeeding or are expected to breastfeed your baby.

Driving and using machines
Monkasta not expected to affect your ability to drive or operate machinery. However, the individual response to treatment may vary. Some side effects (eg. Sleepiness), which reported very rarely when taking Monkasta may affect some patients the ability to drive or operate machinery.

Important information about some of the ingredients of Monkasta
Monkasta contains lactose. If your doctor has told you that you have an intolerance to some sugars you should consult them before you start taking this medicine.

3. HOW TO TAKE MONKASTA?
Always take Monkasta exactly as you told your doctor. If you are not sure, you should consult with your doctor or pharmacist.
Take Monkasta orally once daily in the evening, with or without food, as you told your doctor.
The usual dosage in adults and adolescents 15 years of age is one tablet of 10 mg daily.
It is important to continue taking the tablets Monkasta in the presence or absence of symptoms, as long as prescribed by your doctor, given to maintain control of your asthma. Monkasta can treat asthma only with continued use.
Monkasta tablets should not be used concurrently with other medicinal products containing the same active ingredient, montelukast.

children
Monkasta 10 mg tablets are not recommended for use in children below 15 years of age.

If you take more than you should Monkasta
If you take more tablets than you should, you should contact your doctor or pharmacist immediately.
In most cases, no reports of adverse reactions. The most common symptoms that have been reported include: thirst, drowsiness, headache, hyperactivity and abdominal pain.
If you forget to take Monkasta
If you forget to take a dose, continue with the next dose as usual. Do not take extra tablets, just continue with the regular schedule of one tablet once daily.
If you have any questions about using this medicine, you should consult your doctor.

4. POSSIBLE SIDE EFFECTS
Like all medicines, Monkasta can cause side effects, although not everybody gets them events.
The most commonly reported adverse reactions in clinical trials were abdominal pain and headache. Usually they were mild and occurred at the same frequency in patients treated with montelukast or placebo (tablets that do not contain any active ingredient).
Very rarely (less than 1 in 10,000 patients) have reported the following side effects in adults and / or children:

Cardiac disorders:
Irregular and / or rapid heart beat (palpitations)
Blood and lymphatic system disorders: increased tendency to bleed

Nervous system disorders:
dizziness, drowsiness, erect of chills, stiffness of the limbs, seizures,

Gastrointestinal disorders:
diarrhea, dry mouth, indigestion (dyspepsia), feeling sick (nausea), malaise (feeling sick)

Skin and subcutaneous tissue disorders:
Angioedema (swelling of face, lips, tongue and / or throat that may cause difficulty in breathing or swallowing), bruises, hives, itching, rash. It is vital to stop taking montelukast and seek immediate medical attention if they experience symptoms of angioedema.

Musculo-skeletal system, bones and connective tissue disorders: pain in joints, muscle pain, muscle cramps.

General disorders and administration site conditions:
Weakness, fatigue, a general feeling of malaise, swelling due to fluid retention,

Immune system disorders:
hypersensitivity reactions including anaphylaxis (severe and rapid allergic reaction) and hepatic eosinophilic (a type of white blood cell) infiltration.

Hepatobiliary disorders:
increase in liver enzymes, hepatitis
Psychiatric disorders:
sleep disturbances including nightmares, hallucinations, insomnia, irritability, anxiety including aggressive behavior.

In very rare cases have been reported for a condition known as Churg-Strauss
syndrome (CSS) in asthmatic patients treated with montelukast.

If you experience any of these symptoms, especially if they become persistent or worsening, seek medical attention immediately: flu-like illness, rapid breathing, erect of chills, stiffness of the limbs and / or rash.

If any of these side effects become serious or you notice any side effects not listed in this leaflet, please tell your doctor.

5. HOW TO STORE MONKASTA?
Keep out of reach of children.
Store in the original package in order to protect from light.
Expiration date
Monkasta not use after the expiry date which is stated on the label.
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION
What contain Monkasta?
The active substance is montelukast (montelukast). One tablet contains 10 mg of montelukast montelukast sodium (as montelukast sodium). Excipients are lactose monohydrate, powdered cellulose, microcrystalline cellulose, croscarmellose sodium and magnesium stearate in the tablet core and hypromellose, titanium dioxide (E 171), talc, propylene glycol, red iron oxide (E 172) and iron oxide yellow (E 172 ) in the film wrap.

Looks Monkasta and contents of the pack?
The film-coated tablets are orange-pink, round, slightly biconvex with bevelled edges.
Available in boxes of 7,10,14, 20, 28, 30.49, 50, 56, 84,90,98,100,140 or 200 film-coated tablets in blister packs.
Not all pack sizes may be marketed.
€ 45.00
Add to Cart
Close